It's long past time that natural health advocates stopped demonizing coffee and caffeine.
Some people are sensitive to caffeine, but there never was any evidence that (in moderation) it “exhausts the adrenal glands” ... a common claim.
Nor are claims that coffee raises levels of the stress hormone cortisol backed by consistent evidence, with some studies finding that it lowers cortisol levels.
Coffee is rich in the polyphenol-type “antioxidants” that make berries, tea, cocoa, onions, and colorful fruits and vegetables so healthy.
In fact, coffee is the richest sources of polyphenols in the average American's diet, and ranks very high among sources of chlorogenic acids, which are some of the most beneficial polyphenols known.
Coffee's documented benefits
A growing body of evidence shows that coffee – and caffeine – offer very real health benefits, including lower risk of premature death, and reduced risk of cardiovascular disease (Ding M et al. 2013; Je Y et al. 2013).
Caffeine may induce antioxidant effects in the body, and it's already been proven beneficial to brain function, memory, and concentration, and improve symptoms in Alzheimer's patients (León-Carmona JR et al. 2011; Nehlig A 2013).
In fact, the results of a clinical study published this month show, for the first time, that caffeine enhances human memory substantially for at least 24 hours after it's consumed (Borota D et al. 2014).
Harvard studies found that men and women who drank one to four cups of caffeinated coffee daily were 58 percent less likely to develop Parkinson's disease (Ascherio A et al. 2001; Palacios N et al. 2012).
Likewise, they found that drinking two to five cups of coffee daily cut the risk of diabetes sharply (Campos H et al. 2007; van Dam RM 2008; Wedick NM et al. 2011).
Liver cancer: A rising risk
Liver cancer is the sixth most common type, and the third leading cause of cancer death, worldwide.
A type called hepatocellular carcinoma or HCC accounts for more than 90 percent of cases, and is linked to hepatitis B and C infections, alcohol, tobacco, obesity, and diabetes.
Rates of HCC continue to rise in the United States, especially among white men aged 45 to 54 years of age … which may be explained by hepatitis C infections acquired during the 1960s and 1970s (El-Serag HB et al. 2004).
Now, research from Italy suggests that coffee may reduce the risk of HCC, very substantially.
Coffee may curb the most common liver cancer
According to an evidence review from Italy, drinking coffee daily may reduce the risk of hepatocellular carcinoma (HCC), by about 40 percent (Bravi F et al. 2013).
Further, some evidence indicates that drinking three cups of coffee per day reduces liver cancer risk by more than 50 percent.
“Our research confirms past claims that coffee is good for your health, and particularly the liver,” said co-author Carlo La Vecchia, MD, from Italy's University of Milan.
As he noted, “The favorable effect of coffee on liver cancer might be mediated by coffee's proven prevention of diabetes, a known risk factor for the disease, or for its beneficial effects on cirrhosis and liver enzymes.” (AGA 2013)
The Italian team performed a meta-analysis (review) of articles published from 1996 through September 2012. They found 16 high-quality epidemiological studies, covering 3,153 cases of HCC.
The results possess considerable credibility, thanks to consistent results across studies, time periods and populations.
However, epidemiological studies cannot prove whether an association between a food or nutrient and reduced disease risk is causal.
The researchers said that the apparent link could in part be due to the fact that patients with liver diseases often reduce their coffee intake.
“It remains unclear whether coffee drinking has an additional role in liver cancer prevention,” added Dr. La Vecchia. “But, in any case, such a role would be limited as compared to what is achievable through the current measures.” (AGA 2013)
Primary liver cancers are largely avoidable through hepatitis B vaccinations, control of hepatitis C transmission, and cutting back on booze.
These three measures could, in principle, prevent more than 90 percent of liver cancers worldwide.
- Ahmed F, Perz JF, Kwong S, Jamison PM, Friedman C, Bell BP. National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003. Prev Chronic Dis. 2008 Jul;5(3):A74. Epub 2008 Jun 15. American Gastroenterological Association (AGA).
- Coffee consumption reduces risk of liver cancer. Accessed at http://www.eurekalert.org/pub_releases/2013-10/aga-ccr102213.php
- Ascherio A, Zhang SM, Hernán MA, Kawachi I, Colditz GA, Speizer FE, Willett WC. Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ann Neurol. 2001 Jul;50(1):56-63.
- Borota D et al. Post-study caffeine administration enhances memory consolidation in humans. Nature Neuroscience (2014) doi:10.1038/nn.3623. Published online 12 January 2014. http://www.nature.com/neuro/journal/vaop/ncurrent/full/nn.3623.html
- Bravi F, Bosetti C, Tavani A, Bagnardi V, Gallus S, Negri E, Franceschi S, La Vecchia C. Coffee drinking and hepatocellular carcinoma risk: a meta-analysis. Hepatology. 2007 Aug;46(2):430-5.
- Bravi F, Bosetti C, Tavani A, Gallus S, La Vecchia C. Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis. Clin Gastroenterol Hepatol. 2013 Nov;11(11):1413-1421.e1. doi: 10.1016/j.cgh.2013.04.039. Epub 2013 May 6.
- Campos H, Baylin A. Coffee consumption and risk of type 2 diabetes and heart disease. Nutr Rev. 2007 Apr;65(4):173-9. Review.
- Ding M, Bhupathiraju SN, Satija A, van Dam RM, Hu FB. Long-Term Coffee Consumption and Risk of Cardiovascular Disease: A Systematic Review and a Dose-Response Meta-Analysis of Prospective Cohort Studies. Circulation. 2013 Nov 7. [Epub ahead of print]
- El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med. 2003 Nov 18;139(10):817-23. Erratum in: Ann Intern Med. 2004 Jan 20;140(2):151.
- Inoue M, Yoshimi I, Sobue T, Tsugane S; JPHC Study Group. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. J Natl Cancer Inst. 2005 Feb 16;97(4):293-300.
- Je Y, Giovannucci E. Coffee consumption and total mortality: a meta-analysis of twenty prospective cohort studies. Br J Nutr. 2013 Nov 27:1-12. [Epub ahead of print]
- Larsson SC, Wolk A. Coffee consumption and risk of liver cancer: a meta-analysis. Gastroenterology. 2007 May;132(5):1740-5. Epub 2007 Mar 24.
- León-Carmona JR, Galano A. Is caffeine a good scavenger of oxygenated free radicals? J Phys Chem B. 2011 Apr 21;115(15):4538-46. doi: 10.1021/jp201383y. Epub 2011 Mar 25.Palacios N, Gao X, McCullough ML, Schwarzschild MA, Shah R, Gapstur S, Ascherio A. Caffeine and risk of Parkinson's disease in a large cohort of men and women. Mov Disord. 2012 Sep 1;27(10):1276-82. doi: 10.1002/mds.25076. Epub 2012 Aug 27.
- Nehlig A Is caffeine a cognitive enhancer? J Alzheimers Dis. 2010;20 Suppl 1:S85-94. doi: 10.3233/JAD-2010-091315. Review.
- Qi H, Li S. Dose-response meta-analysis on coffee, tea and caffeine consumption with risk of Parkinson's disease. Geriatr Gerontol Int. 2013 Jul 23. doi: 10.1111/ggi.12123. [Epub ahead of print]
- van Dam RM. Coffee consumption and risk of type 2 diabetes, cardiovascular diseases, and cancer. Appl Physiol Nutr Metab. 2008 Dec;33(6):1269-83. doi: 10.1139/H08-120. Review.
- Wedick NM, Brennan AM, Sun Q, Hu FB, Mantzoros CS, van Dam RM. Effects of caffeinated and decaffeinated coffee on biological risk factors for type 2 diabetes: a randomized controlled trial. Nutr J. 2011 Sep 13;10:93. doi: 10.1186/1475-2891-10-93.